Clinical Trials Browser

Recruiting × Brain Neoplasms × cabozantinib × Clear all

NCT05048212 2026-04-09

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

Phase 2 Recruiting

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell